These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3745135)

  • 21. Encephalopathy during amitriptyline therapy: are neuroleptic malignant syndrome and serotonin syndrome spectrum disorders?
    Miyaoka H; Kamijima K
    Int Clin Psychopharmacol; 1995 Nov; 10(4):265-7. PubMed ID: 8748050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome and hypothyroidism.
    Moore AP; Macfarlane IA; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 1990 Jun; 53(6):517-8. PubMed ID: 2380733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A cocaine-induced variant of the neuroleptic malignant syndrome. A case study].
    Smidt MH; Collumbien EC
    Tijdschr Psychiatr; 2006; 48(5):399-404. PubMed ID: 16956032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome with promethazine.
    Mendhekar DN; Andrade CR
    Aust N Z J Psychiatry; 2005 Apr; 39(4):310. PubMed ID: 15777370
    [No Abstract]   [Full Text] [Related]  

  • 26. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
    Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroleptic malignant syndrome-dopamine-serotonin syndrome--the physiopathology, diagnosis, and therapy].
    Naito Y
    Seishin Shinkeigaku Zasshi; 1997; 99(10):803-8. PubMed ID: 9465737
    [No Abstract]   [Full Text] [Related]  

  • 30. Misconceptions and inappropriate use of terms in hyperthermic syndromes.
    Van Hilten BJ; Roos RA
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):941-2. PubMed ID: 1744662
    [No Abstract]   [Full Text] [Related]  

  • 31. [Neuroleptic malignant syndrome in the elderly: description of 4 patients].
    Cruz JM; Pato M; Gómez XA; Batalla A; Cutrin C
    An Med Interna; 1997 Aug; 14(8):415-8. PubMed ID: 9376483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sympathoadrenal hyperactivity and neuroleptic malignant syndrome.
    Qureshi NA; Al-Habeeb TA
    Am J Psychiatry; 2000 Feb; 157(2):310-1. PubMed ID: 10671434
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome.
    Nicholson D; Chiu W
    Geriatrics; 2004 Aug; 59(8):36, 38-40. PubMed ID: 15332415
    [No Abstract]   [Full Text] [Related]  

  • 34. [Malignant neuroleptic syndrome associated to risperidone].
    Aguirre C; García Monco JC; Mendibil B
    Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy.
    Peritogiannis V; Tsouli S; Pappas D; Mavreas V; Konitsiotis S
    Clin Neuropharmacol; 2007; 30(4):245-6. PubMed ID: 17762322
    [No Abstract]   [Full Text] [Related]  

  • 37. Delayed onset of neuroleptic malignant syndrome after discontinuation of thioridazine.
    Kasckow J; Dolor R; Lipper S
    J Clin Psychopharmacol; 1990 Apr; 10(2):146. PubMed ID: 2341591
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome.
    Lenhard T; Külkens S; Schwab S
    Arch Neurol; 2007 Jan; 64(1):122-5. PubMed ID: 17210819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuroleptic malignant syndrome--sequela of an individually relatively high neuroleptic dosage?].
    Bechter K
    Nervenarzt; 1997 Jul; 68(7):601. PubMed ID: 9333725
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuroleptic malignant syndrome after aortic valve replacement; report of a case].
    Ichiba T; Takemoto N
    Kyobu Geka; 2003 Sep; 56(10):872-4. PubMed ID: 13677924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.